New protein drug shows promise for soothing acute gout attacks
NCT ID NCT05925166
First seen Apr 29, 2026 · Last updated May 10, 2026 · Updated 2 times
Summary
This study tested a protein drug called rhTNFR-Fc in 26 adults with acute gout to see if it safely reduces joint pain and delays the next flare-up. Participants had a gout attack within 4 days before starting and rated their pain on a 0-10 scale. The goal was to find a new way to quickly ease symptoms and improve quality of life during acute episodes.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ACUTE GOUT are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Department of Rheumatology and Clinical Immunology, Jiangxi Provincial People's Hospital
Nanchang, Jiangxi, 330000, China
Conditions
Explore the condition pages connected to this study.